Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Ovid Therapeutics (OVID) Receivables - Other (2016 - 2021)

Ovid Therapeutics filings provide 5 years of Receivables - Other readings, the most recent being $1.0 million for Q1 2021.

  • Quarterly Receivables - Other rose 173.56% to $1.0 million in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Mar 2021, up 173.56% year-over-year, with the annual reading at $141763.0 for FY2020, 87.47% down from the prior year.
  • Receivables - Other hit $1.0 million in Q1 2021 for Ovid Therapeutics, up from $141763.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $4.5 million in Q3 2018 and bottomed at $141763.0 in Q4 2020.
  • Average Receivables - Other over 4 years is $1.2 million, with a median of $836393.0 recorded in 2020.
  • The largest annual shift saw Receivables - Other crashed 87.47% in 2020 before it skyrocketed 173.56% in 2021.
  • Ovid Therapeutics' Receivables - Other stood at $600104.0 in 2018, then surged by 88.49% to $1.1 million in 2019, then crashed by 87.47% to $141763.0 in 2020, then skyrocketed by 622.18% to $1.0 million in 2021.
  • Per Business Quant, the three most recent readings for OVID's Receivables - Other are $1.0 million (Q1 2021), $141763.0 (Q4 2020), and $648995.0 (Q3 2020).